Monitoring the Side Effects of Cancer Chemotherapy with Patients-The Participation of Patients in Cancer Therapy and Sharing Patient Information-

DOI Web Site Web Site 6 Citations 39 References
  • KAWAZOE Hitoshi
    Department of Pharmacy, Kagawa University Hospital Department of Clinical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokushima
  • KUBO Tomomi
    Department of Pharmacy, Kagawa University Hospital
  • IIHARA Naomi
    Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University
  • DOI Chiaki
    Department of Pharmacy, Kagawa University Hospital
  • OKUJYOH Makiko
    Department of Pharmacy, Kagawa University Hospital
  • FUKUOKA Noriyasu
    Department of Pharmacy, Kagawa University Hospital
  • FUJIMOTO Satoshi
    Department of Nursing, Kagawa University Hospital
  • KANAJI Nobuhiro
    First Department of Internal Medicine, Kagawa University Hospital
  • BANDOH Shuji
    First Department of Internal Medicine, Kagawa University Hospital
  • ISHIDA Toshihiko
    First Department of Internal Medicine, Kagawa University Hospital
  • TAKIGUCHI Yoshiharu
    Department of Clinical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokushima
  • HOUCHI Hitoshi
    Department of Pharmacy, Kagawa University Hospital

Bibliographic Information

Other Title
  • 患者参加型癌化学療法副作用モニタリング―患者の治療参加と情報の共有化―
  • カンジャ サンカガタガン カガク リョウホウ フクサヨウ モニタリング カンジャ ノ チリョウ サンカ ト ジョウホウ ノ キョウユウカ

Search this article

Abstract

  The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that “participation of pharmacists in cancer chemotherapy” was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 126 (8), 629-642, 2006

    The Pharmaceutical Society of Japan

Citations (6)*help

See more

References(39)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top